Glover D K, Ruiz M, Edwards N C, Cunningham M, Simanis J P, Smith W H, Watson D D, Beller G A
Department of Medicine, University of Virginia, Charlottesville 22908.
Circulation. 1995 Feb 1;91(3):813-20. doi: 10.1161/01.cir.91.3.813.
Myocardial uptake of either 201Tl or 99mTc-sestamibi (sestamibi) is known to plateau at high coronary flow rates. However, few direct comparisons have been made between these tracers to determine what effect differences in the uptake plateau for the two tracers may have on the detection of coronary stenoses of various severities.
Twenty-two dogs were instrumented with flow transducers on the left anterior descending (LAD) and circumflex (LCx) arteries. In 6 nonstenotic dogs, adenosine was infused directly into the LAD, whereas 16 dogs with either critical (n = 7) or mild (n = 9) LAD stenoses received an intravenous infusion. At peak flow, 201Tl (0.5 mCi), sestamibi (5 to 8 mCi), and radiolabeled microspheres were injected simultaneously. Five minutes later, dogs were killed, and ex vivo imaging of heart slices and gamma-well counting of multiple myocardial samples was performed. Neither 201Tl nor sestamibi uptake increased in direct proportion to flow. In the 6 nonstenotic dogs, a fivefold increase in LAD flow increased 201Tl and sestamibi uptake by only 202 +/- 6% and 138 +/- 4%, respectively (P < .0001). In the dogs with critical stenosis, the ratios of stenotic to normal activity by well counting for 201Tl (0.37 +/- 0.05) and sestamibi (0.53 +/- 0.06) underestimated the microsphere-determined flow disparity (0.17 +/- 0.03) (P < .005), but the degree of underestimation was greater for sestamibi (P = .001). Similarly, in the dogs with mild stenosis, the stenotic-to-normal ratio for 201Tl (0.62 +/- 0.04) approximated the flow ratio (0.43 +/- 0.04) better than sestamibi (0.79 +/- 0.03) (P < .0001). Sestamibi defects, however, were visually identifiable on the images of the myocardial slices. By image quantification, sestamibi defect magnitude (LAD-to-LCx count ratio) in the critical stenosis group (0.62 +/- 0.05) was significantly less than in the mild stenosis group (0.80 +/- 0.02) (P < .01).
Thus, with adenosine-induced hyperemic flow, both 201Tl and sestamibi significantly underestimated the magnitude of the flow disparity between stenotic and normal perfusion beds. The degree of underestimation was greater for sestamibi. The clinical implication of these experimental findings for vasodilator perfusion imaging remains to be determined, since factors such as greater redistribution and scatter with 201Tl could offset its advantages.
已知201铊(201Tl)或锝99m - 甲氧基异丁基异腈(99mTc - sestamibi,甲氧基异丁基异腈)在高冠状动脉血流率时心肌摄取会达到平台期。然而,很少有人对这两种示踪剂进行直接比较,以确定两种示踪剂摄取平台期的差异对不同严重程度冠状动脉狭窄检测的影响。
22只犬在左前降支(LAD)和回旋支(LCx)动脉上安装了血流传感器。6只无狭窄的犬,将腺苷直接注入LAD,而16只患有严重(n = 7)或轻度(n = 9)LAD狭窄的犬接受静脉输注。在血流峰值时,同时注射201Tl(0.5毫居里)、甲氧基异丁基异腈(5至8毫居里)和放射性标记微球。5分钟后,处死犬,进行心脏切片的体外成像和多个心肌样本的γ计数。201Tl和甲氧基异丁基异腈的摄取均未与血流成正比例增加。在6只无狭窄的犬中,LAD血流增加五倍时,201Tl和甲氧基异丁基异腈摄取仅分别增加202±6%和138±4%(P <.0001)。在严重狭窄的犬中,通过计数法得出的201Tl(0.37±0.05)和甲氧基异丁基异腈(0.53±0.06)狭窄与正常活性之比低估了微球测定的血流差异(0.17±0.03)(P <.005),但甲氧基异丁基异腈的低估程度更大(P =.001)。同样,在轻度狭窄的犬中,201Tl的狭窄与正常之比(0.62±0.04)比甲氧基异丁基异腈(0.79±0.03)更接近血流比(0.43±0.04)(P <.0001)。然而,在心肌切片图像上可以目视识别甲氧基异丁基异腈缺损。通过图像定量分析,严重狭窄组中甲氧基异丁基异腈缺损大小(LAD与LCx计数比)(0.62±0.05)明显小于轻度狭窄组(0.80±0.02)(P <.01)。
因此,在腺苷诱导的充血血流情况下,201Tl和甲氧基异丁基异腈均显著低估了狭窄与正常灌注床之间的血流差异程度。甲氧基异丁基异腈的低估程度更大。这些实验结果对血管扩张剂灌注成像的临床意义仍有待确定,因为诸如201Tl更大的再分布和散射等因素可能抵消其优势。